Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 473 All time
- Disclosed funding
- $19.6B 400 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| T TurbineCompany profile Virtualizes biological experiments with AI to accelerate drug discovery and clinical translation Virtualizes biological experiments with AI to accelerate drug discovery and clinical translation | $25M | Series B | Biotech | Hungary | Investors | |
| SM Slate MedicinesCompany profile Advancing next-generation therapeutics for migraine and other headache disorders Advancing next-generation therapeutics for migraine and other headache disorders | $130M | Series A | Biotech | United States | Investors | |
| V VerleyCompany profile Develops functional whey protein ingredients through precision fermentation for food and nutrition manufacturers Develops functional whey protein ingredients through precision fermentation for food and nutrition manufacturers | €32M | Series A | Biotech, Foodtech | France | Investors | |
| CT Centauri TherapeuticsCompany profile Develops immunotherapeutic treatments for antimicrobial infections Develops immunotherapeutic treatments for antimicrobial infections | £6M | Series A+Series A | Biotech | United Kingdom | Investors | |
| TT Ten63 TherapeuticsCompany profile Develops AI-driven drug discovery platform for first- and best-in-class therapeutics Develops AI-driven drug discovery platform for first- and best-in-class therapeutics | $45M | StrategicUndisclosed | Biotech, AI | United States | Investors | |
| AB Altesa BioSciencesCompany profile Clinical-stage developer of oral antiviral medicines for people with chronic lung disease. Clinical-stage developer of oral antiviral medicines for people with chronic lung disease. | $75M | Series B | Biotech | United States | Investors | |
| L LanzaJetCompany profile Develops technology for producing Sustainable Aviation Fuel (SAF) and other alternative fuels Develops technology for producing Sustainable Aviation Fuel (SAF) and other alternative fuels | $47M | Growth | Biotech, Climate tech | United States | Investors | |
| LT Lario TherapeuticsCompany profile Develops precision medicines for epileptic and neurological disorders Develops precision medicines for epileptic and neurological disorders | $2.4M | GrantUndisclosed | Biotech | United Kingdom | Investors | |
| F FlinnCompany profile Develops AI-based software to automate regulatory and quality processes in medtech and pharma Develops AI-based software to automate regulatory and quality processes in medtech and pharma | $20M | Series A | Biotech, Healthtech | Austria | Investors | |
| KB Develops therapies for neurodegenerative diseases. | $175M | Series A | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1RA Capital Management
Estuary Biotherapeutics, Circle Pharma, Inc., Solstice Oncology
22rounds3led - 2Janus Henderson Investors
Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics
15rounds1led - 3Eli Lilly and Company
BigHat Biosciences, Circle Pharma, Inc., Moonwalk Biosciences
15rounds0led - 4ARCH Venture Partners
Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences
14rounds0led - 5OrbiMed
Star Therapeutics, Leal Therapeutics, Accro Bioscience
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →